Society for Endocrinology - a world-leading authority on hormones


Issue 145 Autumn 2022

Endocrinologist > Autumn 2022 > Hot topics


DIAGNOSTIC SCANS IN MANAGEMENT OF INTERMEDIATE RISK THYROID CANCER

| Hot topics



Diagnostic whole body scanning is widely used to establish the indication and administration activity for radioiodine therapy in intermediate risk differentiated thyroid carcinomas. However, its predictive value is not universally accepted.

In this retrospective study, Danilovic et al. analysed pre-therapy stimulated thyroglobin levels combined with diagnostic whole body scanning and post-therapy whole body scanning findings and compared these with outcomes. Diagnostic whole body scanning identified 10.6% of patients with functioning metastases and led to modified patient management in 8.3%.

The authors ultimately concluded that a stimulated thyroglobin level <1ng/ml in combination with a negative diagnostic whole body scan is highly suggestive of the absence of remaining malignant disease, leading to a much more patient-centred approach to care.

Read the full article in Endocrine-Related Cancer 29 475–483

 




This Issue:

Autumn 2022

Autumn 2022